Many previous reports have also suggested the possible link between CSC and p53 status, with CSC markers such as CD133 and CD44 being repressed in wild-type p53 while, their expression contributing to the CSC characteristics in various mutant p53 cancer cell types (88, 89). The gene discussed is PROM1; the disease is cancer.